We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

214 hedge funds and large institutions have $1.82B invested in Beam Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $16.6M | Put options by funds: $7.11M

18% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 62

8.14% more ownership

Funds ownership: 86.14% → 94.28% (+8.1%)

3% less funds holding

Funds holding: 221 → 214 (-7)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

22% less capital invested

Capital invested by funds: $2.32B → $1.82B (-$504M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
214
Holders Change
-7
Holders Change %
-3.17%
% of All Funds
3.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
36
Increased
73
Reduced
62
Closed
41
Calls
$16.6M
Puts
$7.11M
Net Calls
+$9.45M
Net Calls Change
+$24.8M

Top Buyers

1
AVM
Arch Venture Management
Illinois
+$134M
2
FCM
Farallon Capital Management
California
+$83.5M
3
First Trust Advisors
First Trust Advisors
Illinois
+$36.4M
4
BlackRock
BlackRock
New York
+$22.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$19.7M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$81.5M
2
DGM
Darwin Global Management
Jersey
-$70M
3
AIM
ARK Investment Management
Florida
-$13.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$12M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$7.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
126
Victory Capital Management
Texas
$232K +$23.9K +973 +11%
CUAMC
127
China Universal Asset Management Company
China
$232K -$148K -6,013 -38%
Pictet Asset Management
128
Pictet Asset Management
Switzerland
$226K -$7.18M -292,364 -97%
HKAM
129
Horizon Kinetics Asset Management
New York
$225K – – –
Creative Planning
130
Creative Planning
Kansas
$223K -$62.4K -2,539 -21%
Mariner
131
Mariner
Kansas
$220K +$30.3K +1,234 +15%
Squarepoint
132
Squarepoint
New York
$218K -$1.12M -45,685 -83%
IEFM
133
IQ EQ Fund Management
Ireland
$218K +$228K +9,303 New
RJFSA
134
Raymond James Financial Services Advisors
Florida
$215K +$10.9K +443 +5%
AQR Capital Management
135
AQR Capital Management
Connecticut
$211K +$61.1K +2,487 +38%
MAM
136
Martingale Asset Management
Massachusetts
$209K +$219K +8,929 New
Canada Life
137
Canada Life
Manitoba, Canada
$207K +$24.7K +1,005 +13%
OQS
138
Occudo Quantitative Strategies
Florida
$206K +$216K +8,800 New
D.E. Shaw & Co
139
D.E. Shaw & Co
New York
$204K +$214K +8,721 New
Royal Bank of Canada
140
Royal Bank of Canada
Ontario, Canada
$202K +$112K +4,543 +112%
AIP
141
Ameritas Investment Partners
Nebraska
$176K – – –
SO
142
STRS Ohio
Ohio
$169K +$140K +5,700 +380%
A
143
AlphaQuest
New York
$166K +$52.4K +2,132 +43%
LSA
144
Leonteq Securities AG
Switzerland
$163K +$150K +6,105 +715%
Public Employees Retirement Association of Colorado
145
Public Employees Retirement Association of Colorado
Colorado
$146K – – –
SOW
146
State of Wyoming
Wyoming
$145K +$152K +6,193 New
ACM
147
Aquatic Capital Management
Illinois
$143K -$44.2K -1,800 -23%
CI Investments Inc
148
CI Investments Inc
Ontario, Canada
$113K +$25.7K +1,046 +28%
GI
149
GAMMA Investing
California
$95.5K +$90.7K +3,691 +959%
QL
150
Quarry LP
New York
$84.3K +$68.8K +2,800 +350%
4 5
6
7 8

BEAM Hedge Fund Activity: Q2 2024 in Review

214 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2024, worth a combined $1.82B — down 22% from $2.32B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of BEAM and 36 opened new positions — a net loss of 5 holders — while 62 trimmed existing stakes and 73 added.

The largest buyer was Arch Venture Management, opening a new position worth an estimated $134M. The largest seller was Morgan Stanley, cutting an estimated $81.5M.

  • 214 institutional investors held Beam Therapeutics (BEAM) as of Q2 2024, down from 221 in Q1 2024.
  • Funds reported $1.82B of Beam Therapeutics stock for Q2 2024, down 22% quarter-over-quarter.
  • 36 funds opened new Beam Therapeutics positions in Q2 2024 and 41 closed out, a net change of -5 holders.
  • The largest Beam Therapeutics buyer in Q2 2024 was Arch Venture Management, an estimated $134M added.
  • The largest Beam Therapeutics seller in Q2 2024 was Morgan Stanley, an estimated $81.5M sold.

Based on aggregated 13F filings for Q2 2024.